Bupropion and its main metabolite reverse nicotine chronic tolerance in the mouse

Nicotine and Tobacco Research

Volumn 14, Issue 11, 2012, Pages 1356-1361

  Grabus, Sheri D ^a   Carroll, Frank Ivy ^b   Damaj, Mohamad Imad ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE TARTRATE; NICOTINIC RECEPTOR; RADAFAXINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; HYPOTHERMIA; MALE; MOUSE; NICOTINE TOLERANCE; NONHUMAN; PRIORITY JOURNAL; RECTUM TEMPERATURE; SMOKING CESSATION; TAIL FLICK TEST; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; BODY TEMPERATURE; BUPROPION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; HYPOTHERMIA, INDUCED; MALE; MICE; NICOTINE; SMOKING CESSATION;

EID: 84868101862     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts088     Document Type: Article

References (31)

1. Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., et al. (1995). Bupropion: A review of its mechanism of antidepressant activity. Journal of Clinical Psychiatry, 56, 395-401
2. Bruijnzeel, A. W., & Markou, A. (2003). Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats. Synapse, 50, 20-28. doi:10.1002/syn.10242
3. Cooper, B. R., Wang, C. M., Cox, R. F., Norton, R., Shea, V., & Ferris, R. M. (1994). Evidence that the acute behavioral and electrophysiological effects of bupropion (Welbutrin) are mediated by a noradrenergic mechanism. Neuropsychopharmacology, 11, 133-141.
4. Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003). Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat Psychopharmacology (Berlin), 168, 347-358. doi:10.1007/s00213-003-1445-7
5. Damaj, M. I., Carroll, F. I., Eaton, J. B., Navarro, H. A., Blough, B. E., Mirza, S., et al. (2004). Enantioselective effects of hydroxy metabolites of bupropion on behaviour and on function of monoamine transporters and nicotinic receptors. Molecular Pharmacology, 66, 675-682. doi:10.1124/mol.104.001313
6. Damaj, M. I., Grabus, S. D., Navarro, H. A., Vann, R. E., Warner, J. A., King, L. S., et al. (2010). Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice. Journal of Pharmacology and Experimental Therapeutics, 334, 1087-1095. doi:10.1124/jpet.110.166850
7. Damaj, M. I., & Martin, B. R. (1993). Is the dopaminergic system involved in the central effects of nicotine in mice? Psychopharmacology (Berlin), 111, 106-108. doi:10.1007/BF022 57415
8. Damaj, M. I., Welch, S. P., & Martin, B. R. (1994). Nicotineinduced antinociception in mice: Role of G-proteins and adenylate cyclase. Pharmacology Biochemistry and Behavior, 48, 37-42. doi:10.1016/0091-3057(94)90494-4
9. Damaj, M. I., Welch, S. P., & Martin, B. R. (1996). Characterization and modulation of acute tolerance to nicotine in mice. Journal of Pharmacology and Experimental Therapeutics, 277, 454-461
10. D'Amour, F. E., & Smith, D. L. (1941). A method for determining loss of pain sensation. Journal of Pharmacology and Experimental Therapeutics, 72, 74-79
11. Fang, Q. K., Han, Z. Y., Grover, P., Kessler, D., Senanayake, C. H., & Wald, S. A. (2000). Rapid acess to enantiopure bupropion and its major metabolite by stereospecifi c nucleophilic substitution on α_-ketotrifl ate. Tetrahedron, 11, 3659-3663
12. George, T. P., & O'Malley, S. S. (2004). Current pharmacological treatments for nicotine dependence. Trends in Pharmacological Sciences, 25, 42-48. doi:10.1016/j.tips.2003.11.003
13. Glick, S. D., Maisonneuve, I. M., & Kitchen, B. A. (2002). Modulation of nicotine self-administration in rats by combination therapy with agents blocking 〈 3 ® 4 nicotinic receptors. European Journal of Pharmacology, 448, 185-191. doi:10.1016/S0014-2999 (02)01944-1
14. Gold, P. B., Rubey, R. N., & Harvey, R. T. (2002). Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care. American Journal of Addictions, 11, 315-331. doi:10.1080/1055049029008811
15. Grabus, S. D., Martin, B. R., Batman, A. M., Tyndale, R. F., Sellers, E., & Damaj, M. I. (2005). Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology (Berlin), 178, 183-192. doi:10.1007/s00213-004-2007-3
16. Jackson, K. J., Martin, B. R., C hangeux, J. P., & Damaj, M. I. (2008). Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. Journal of Pharmacology and Experimental Therapeutics, 325, 302-312.
17. Marubio, L. M., del Mar Arroyo-Jimenez, M., Cordero-Erausquin, M., Léna, C., Le Novère, N., et al. (1999). Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature, 398, 805-810.
18. McCallum, S. E., Caggiula, A. R., Epstein, L. H., Saylor, S., Ploskina, T., & Sved, A. F. (1999). Mecamylamine blocks the development of tolerance to nicotine in rats: Implications for the mechanisms of tolerance. Psychopharmacology (Berlin), 141, 332-338. doi:10.1007/s002130050842
19. Paterson, N. E. (2009). Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: Recent preclinical and clinical insights. European Journal of Pharmacology, 603, 1-11. doi:10.1016/j.ejphar.2008.12.009
20. Paterson, N. E., Balfour, D. J., & Markou, A. (2007). Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. European Journal of Neuroscience, 25, 3099-3108.
21. Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., et al. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature, 391, 173-177.
22. Rauhut, A. S., Neugebauer, N., Dwoskin, L. P., & Bardo, M. T. (2003). Effect of bupropion on nicotine self-administration in rats. Psychopharmacology (Berlin), 169, 1-9. doi:10.1007/s00213-003-1450-x
23. Robinson, S. F., Grun, E. U., Pauly, J. R., & Collins, A. C. (1996). Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice. Pharmacology Biochemistry and Behavior, 54, 587-593. doi:10.1016/0091-3057(95)02281-3
24. Rogers, D. T., & Iwamoto, E. T. (1993). Multiple spinal mediators in parenteral nicotine-induced antinociception. Journal of Pharmacology and Experimental Therapeutics, 267, 341-349.
25. Shiffman, S., Johnston, J. A., Khayrallah, M., Elash, C. A., Gwaltney, C. J., Paty, J. A., et al. (2000). The effect of bupropion on nicotine craving and withdrawal. Psychopharmacology (Berlin), 148, 33-40. doi:10.1007/s002130050022
26. Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000). Bupropion is a nicotinic antagonist. Journal of Pharmacology and Experimental Therapeutics, 295, 321-327.
27. Suckow, R. F., Smith, T. M., Perumal, A. S., & Cooper, T. B. (1986). Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. Drug Metabolism and Disposition, 14, 692-697.
28. Tritto, T., McCallum, S. E., Waddle, S. A., Hutton, S. R., Paylor, R., Collins, A. C., et al. (2004). Null mutant analysis of responses to nicotine: Deletion of beta2 nicotinic acetylcholine receptor subunit but not alpha7 subunit reduces sensitivity to nicotine-induced locomotor depression and hypothermia. Nicotine & Tobacco Research, 6, 145-158. doi:10.1080/14622200 310001656966
29. Walters, C. L., Brown, S., Changeux, J. P., Martin, B., & Damaj, M. I. (2006). The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotineconditioned place preference in mice. Psychopharmacology (Berlin), 184, 339-344. doi:10.1007/s00213-005-0295-x
30. Welch, R. M., Lai, A. L., & Schroeder, D. H. (1987). Pharmacological signifi cance of the species differences in bupropion metabolism. Xenobiotica, 17, 287-298. doi:10.3109/004982 58709043939
31. Wiley, J. L., Lavecchia, K. L., Martin, B. R., & Damaj, M. I. (2002). Nicotine-like discriminative stimulus effects of bupropion in rats. Experimental and Clinical Psychopharmacology, 10, 129-135. doi:10.1037//1064-1297.10.2.129